Literature DB >> 10900482

Modelling a predictable disaster: the rise and spread of drug-resistantmalaria.

I M Hastings1, U D'Alessandro.   

Abstract

The evolution of drug-resistant malaria is one of the most important factors thwarting the development of effective malaria disease control. Several mathematical models have been developed to try and understand the dynamics of this process and how it can be slowed or even avoided. Much of the mathematics describing the evolution of drug resistance in malaria focuses on the derivation and mechanics of the calculations, which can make it inaccessible to experimentalists and field workers. In this article, Ian Hastings and Umberto D'Alessandro describe general model results without recourse to mathematical details, identify the factors that should be considered in the design of drug control programmes, and discuss the crucial parameters that remain unknown and need to be measured in the field or laboratory.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10900482     DOI: 10.1016/s0169-4758(00)01707-5

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  52 in total

Review 1.  The evolution of drug-resistant malaria: the role of drug elimination half-life.

Authors:  Ian M Hastings; William M Watkins; Nicholas J White
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-04-29       Impact factor: 6.237

Review 2.  History, dynamics, and public health importance of malaria parasite resistance.

Authors:  Ambrose O Talisuna; Peter Bloland; Umberto D'Alessandro
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

3.  Chemotherapy, within-host ecology and the fitness of drug-resistant malaria parasites.

Authors:  Silvie Huijben; William A Nelson; Andrew R Wargo; Derek G Sim; Damien R Drew; Andrew F Read
Journal:  Evolution       Date:  2010-08-19       Impact factor: 3.694

4.  Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening.

Authors:  Jacob D Johnson; Richard A Dennull; Lucia Gerena; Miriam Lopez-Sanchez; Norma E Roncal; Norman C Waters
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

5.  Assessment of malaria in vitro drug combination screening and mixed-strain infections using the malaria Sybr green I-based fluorescence assay.

Authors:  Edgie-Mark A Co; Richard A Dennull; Drew D Reinbold; Norman C Waters; Jacob D Johnson
Journal:  Antimicrob Agents Chemother       Date:  2009-04-06       Impact factor: 5.191

6.  A quantitative model of population dynamics in malaria with drug treatment.

Authors:  Le Thi Thanh An; Willi Jäger
Journal:  J Math Biol       Date:  2013-08-04       Impact factor: 2.259

7.  Exposing malaria in-host diversity and estimating population diversity by capture-recapture using massively parallel pyrosequencing.

Authors:  Jonathan J Juliano; Kimberly Porter; Victor Mwapasa; Rithy Sem; William O Rogers; Frédéric Ariey; Chansuda Wongsrichanalai; Andrew Read; Steven R Meshnick
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

8.  The de novo selection of drug-resistant malaria parasites.

Authors:  N J White; W Pongtavornpinyo
Journal:  Proc Biol Sci       Date:  2003-03-07       Impact factor: 5.349

Review 9.  Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems.

Authors:  Ambrose O Talisuna; Corine Karema; Bernhards Ogutu; Elizabeth Juma; John Logedi; Andrew Nyandigisi; Modest Mulenga; Wilfred F Mbacham; Cally Roper; Philippe J Guerin; Umberto D'Alessandro; Robert W Snow
Journal:  Lancet Infect Dis       Date:  2012-11       Impact factor: 25.071

Review 10.  Antimalarial drug resistance.

Authors:  Nicholas J White
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.